Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01521442|
Recruitment Status : Withdrawn (Did not have funding or resources to carry out study)
First Posted : January 30, 2012
Last Update Posted : December 19, 2014
|Condition or disease||Intervention/treatment||Phase|
|PTSD||Behavioral: Mindful Yoga Therapy Behavioral: Wait-list Control||Phase 1 Phase 2|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans: A Pilot Study|
|Study Start Date :||April 2013|
|Estimated Primary Completion Date :||September 2015|
|Estimated Study Completion Date :||November 2015|
Experimental: Arm 1
12 sessions of Mindful Yoga Therapy delivered two times per week for 75 minutes each.
Behavioral: Mindful Yoga Therapy
Veterans will participate in twice weekly Mindful Yoga Therapy, which includes meditation, breathing practices, mindful movement, and guided rest (yoga nidra), as well as daily home practice.
12-week delay before beginning Mindful Yoga Therapy treatment which will consist of 12 sessions of Mindful Yoga Therapy delivered two times per week for 75 minutes each.
Behavioral: Wait-list Control
Participants will receive Mindful Yoga Therapy intervention after 12 weeks from being enrolled. Veterans will participate in twice weekly Mindful Yoga Therapy, which includes meditation, breathing practices, mindful movement, and guided rest (yoga nidra), as well as daily home practice.
- Clinician Administered PTSD Scale (CAPS) [ Time Frame: 12 weeks ]The "gold standard" measure of frequency and intensity of PTSD symptoms.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01521442
|United States, Connecticut|
|VA Connecticut Healthcare System|
|West Haven, Connecticut, United States, 06516|
|Principal Investigator:||Alicia Heapy, Ph.D.||VA Connecticut Healthcare System|